Waters (WAT) Stock Forecast & Price Target

$380.94 +2.97 (+0.78%)

Closing price 02/20/2025 03:59 PM Eastern

Extended Trading

$379.96 -0.98 (-0.26%)

As of 08:35 AM Eastern

Waters - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 16 Analyst Ratings

Sell
0

Hold
10

Buy
6

Based on 16 Wall Street analysts who have issued ratings for Waters in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 10 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for WAT.

Consensus Price Target

$390.40
2.48% Upside

According to the 16 analysts' twelve-month price targets for Waters, the average price target is $390.40. The highest price target for WAT is $450.00, while the lowest price target for WAT is $312.00. The average price target represents a forecasted upside of 2.48% from the current price of $380.94.

Get the Latest News and Ratings for WAT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Waters and its competitors.

WAT Analyst Ratings Over Time

Type	Current Forecast 2/22/24 to 2/21/25	1 Month Ago 1/23/24 to 1/22/25	3 Months Ago 11/24/23 to 11/23/24	1 Year Ago 2/22/23 to 2/22/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	0 Buy rating(s)
Hold	10 Hold rating(s)	9 Hold rating(s)	10 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$390.40	$384.71	$365.85	$293.50
Forecasted Upside	2.48% Upside	-5.80% Downside	-2.04% Downside	-11.21% Downside
Consensus Rating	Hold	Hold	Hold	Reduce

WAT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WAT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Waters Stock vs. The Competition

Type	Waters	Medical Companies	S&P 500
Consensus Rating Score	2.44	2.82	2.53
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	2.48% Upside	28,644.17% Upside	12.82% Upside
News Sentiment Rating	Neutral News See Recent WAT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/13/2025	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$415.00 ➝ $420.00	+10.21%
2/13/2025	UBS Group 4 of 5 stars	Elizabeth Garcia Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$405.00 ➝ $410.00	+8.39%
2/13/2025	Scotiabank 5 of 5 stars	S. Nam Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$430.00 ➝ $450.00	+17.66%
2/13/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Derik De Bruin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$430.00 ➝ $410.00	+7.20%
2/10/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$360.00 ➝ $415.00	+1.48%
1/10/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Burstein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$430.00	+15.06%
11/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$310.00 ➝ $325.00	-15.59%
11/4/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$363.00 ➝ $410.00	+6.73%
11/4/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$332.00 ➝ $360.00	-7.00%
11/4/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$340.00 ➝ $380.00	-2.10%
Get the Latest News and Ratings for WAT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.
10/17/2024	Cfra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jonathan Sakraida Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$389.00	+10.50%
10/8/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$355.00 ➝ $415.00	+18.60%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$335.00 ➝ $355.00	-0.39%
8/1/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Souda Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/1/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$325.00 ➝ $375.00	+11.51%
7/31/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Sykes Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/8/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$319.00 ➝ $312.00	-4.31%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
12/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$265.00 ➝ $300.00	+2.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:44 AM ET.

WAT Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Waters is $390.40, with a high forecast of $450.00 and a low forecast of $312.00.
: 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last twelve months. There are currently 10 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" WAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
: According to analysts, Waters's stock has a predicted upside of 2.48% based on their 12-month stock forecasts.
: Over the previous 90 days, Waters's stock had 3 upgrades by analysts.
: Waters has been rated by research analysts at Bank of America, Barclays, Sanford C. Bernstein, Scotiabank, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Waters less than other "medical" companies. The consensus rating for Waters is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how WAT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:WAT) was last updated on 2/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waters (WAT) Stock Forecast & Price Target